Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shicheng Su

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Nature Communications|May 12, 2021
An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemnessLei Liu, Tianyu Tao, Shihua Liu, et al.
Nature Cancer|February 5, 2022
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancerJiang Liu, Liyan Lao, Jianing Chen, et al.
Nature Cancer|April 28, 2022
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competitionJiang Li, Yingying Ye, Zhihan Liu, et al.
Science Advances|July 25, 2025
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by <i>BRCA1</i> mutationJingxin Liu, Cai Zhao, Jiahao Chen, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Nature Communications|May 12, 2021
An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemnessLei Liu, Tianyu Tao, Shihua Liu, et al.
Nature Cancer|February 5, 2022
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancerJiang Liu, Liyan Lao, Jianing Chen, et al.
Nature Cancer|April 28, 2022
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competitionJiang Li, Yingying Ye, Zhihan Liu, et al.
Science Advances|July 25, 2025
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by <i>BRCA1</i> mutationJingxin Liu, Cai Zhao, Jiahao Chen, et al.
Pageof 7